GUIDED Development

Guided Development is a privately held, revenue-generating service provider in the biotech sector, specializing in clinical development consulting. Leveraging the deep expertise of its founder, Dr. Rico Laage, the company supports a diverse clientele through the complexities of drug development, including program strategy, vendor selection, and regulatory compliance. While not developing its own therapeutics, it plays a critical role in accelerating external pipelines, particularly in neurology, oncology, and infectious diseases, as evidenced by its involvement in published clinical studies. The company operates as a boutique firm, likely with a small team, serving the European biotech ecosystem.

Integrated clinical development consultancy service model based on therapeutic area expertise, GCP compliance, quality management, and a network of partners (CROs, investigators). No proprietary therapeutic technology.

Guided Development competes in the fragmented clinical development consulting market. Competitors range from large, global Contract Research Organizations (CROs) that offer full-service outsourcing to solo consultants and boutique firms. Its differentiation lies in its specific focus on small biotech/startup clients, deep hands-on experience in complex therapeutic areas like stroke, and a flexible, guidance-oriented service model as opposed to pure labor outsourcing.